Literature DB >> 18618122

Peripheral contrast-enhanced MR angiography at 3.0T, improved spatial resolution and low dose contrast: initial clinical experience.

Kambiz Nael1, Mayil Krishnam, Ali Nael, Anthony Ton, Stefan G Ruehm, J Paul Finn.   

Abstract

To investigate a high spatial resolution peripheral contrast-enhanced MR angiography (CE-MRA) protocol, applying a dedicated multi-channel array coil and accelerated parallel acquisition at 3.0T in evaluation of patients with peripheral vascular disease. Twenty patients with peripheral vascular disease underwent multi-station high spatial resolution peripheral CE-MRA at 3T. The image quality, presence of venous contamination, image noise, and artifact were evaluated by 2 radiologists independently. Assessment of arterial disease for 540 arterial segments was performed, and findings were correlated with conventional catheter angiography in 10 patients. All studies were yielded high diagnostic image quality. Venous contamination and artifact were minimal and never interfered with diagnosis. Sixty seven arterial segments with significant stenoses (>0%) were detected by observers with excellent interobserver agreement (kappa = 0.82; 95% CI: 0.76, 0.88). There was a significant correlation between CE-MRA and conventional angiography (Rs = 0.91 and 0.94 for reader 1 and 2, respectively) for the assessment of the degree of stenosis. Higher available SNR at 3T in combination with multi-coil technology and accelerated parallel acquisition, result in acquisition of nearly isotropic submillimeter 3D voxels throughout the entire peripheral arterial tree with diagnostic image quality and favorable comparative analysis with catheter angiography.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18618122     DOI: 10.1007/s00330-008-1074-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

1.  Dielectric resonances and B(1) field inhomogeneity in UHFMRI: computational analysis and experimental findings.

Authors:  T S Ibrahim; R Lee; A M Abduljalil; B A Baertlein; P M Robitaille
Journal:  Magn Reson Imaging       Date:  2001-02       Impact factor: 2.546

2.  Generalized autocalibrating partially parallel acquisitions (GRAPPA).

Authors:  Mark A Griswold; Peter M Jakob; Robin M Heidemann; Mathias Nittka; Vladimir Jellus; Jianmin Wang; Berthold Kiefer; Axel Haase
Journal:  Magn Reson Med       Date:  2002-06       Impact factor: 4.668

3.  Signal-to-noise ratio and parallel imaging performance of a 16-channel receive-only brain coil array at 3.0 Tesla.

Authors:  Jacco A de Zwart; Patrick J Ledden; Peter van Gelderen; Jerzy Bodurka; Renxin Chu; Jeff H Duyn
Journal:  Magn Reson Med       Date:  2004-01       Impact factor: 4.668

4.  High spatial resolution contrast-enhanced MR angiography of the supraaortic arteries using the quadrature body coil at 3.0T: a feasibility study.

Authors:  Winfried A Willinek; Thomas Bayer; Jürgen Gieseke; Marcus von Falkenhausen; Torsten Sommer; Romhild Hoogeveen; Kai Wilhelm; Horst Urbach; Hans H Schild
Journal:  Eur Radiol       Date:  2006-08-30       Impact factor: 5.315

5.  Cardiovascular screening with parallel imaging techniques and a whole-body MR imager.

Authors:  Harald Kramer; Stefan O Schoenberg; Konstantin Nikolaou; Armin Huber; Anja Struwe; Eva Winnik; Bernd J Wintersperger; Olaf Dietrich; Berthold Kiefer; Maximilian F Reiser
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

6.  Field-of-view limitations in parallel imaging.

Authors:  Mark A Griswold; Stephan Kannengiesser; Robin M Heidemann; Jianmin Wang; Peter M Jakob
Journal:  Magn Reson Med       Date:  2004-11       Impact factor: 4.668

7.  Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays.

Authors:  D K Sodickson; W J Manning
Journal:  Magn Reson Med       Date:  1997-10       Impact factor: 4.668

8.  Rapid magnetic resonance angiography for detection of atherosclerosis.

Authors:  S G Ruehm; M Goyen; J Barkhausen; K Kröger; S Bosk; M E Ladd; J F Debatin
Journal:  Lancet       Date:  2001-04-07       Impact factor: 79.321

9.  The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.

Authors:  Val M Runge; Jonmenjoy Biswas; Bernd J Wintersperger; Shannon S Baumann; Carney B Jackson; Christoph U Herborn; Tushar Patel
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

10.  Lower extremity stepping-table magnetic resonance angiography with multilevel contrast timing and segmented contrast infusion.

Authors:  Mark D Morasch; Jeremy Collins; F Scott Pereles; James C Carr; Mark K Eskandari; William H Pearce; J Paul Finn
Journal:  J Vasc Surg       Date:  2003-01       Impact factor: 4.268

View more
  6 in total

1.  Magnetic resonance angiography (MRA) of the calf station at 3.0 T: intraindividual comparison of non-enhanced ECG-gated flow-dependent MRA, continuous table movement MRA and time-resolved MRA.

Authors:  Stefan Haneder; Ulrike I Attenberger; Philipp Riffel; Thomas Henzler; Stefan O Schoenberg; Henrik J Michaely
Journal:  Eur Radiol       Date:  2011-01-28       Impact factor: 5.315

Review 2.  Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions.

Authors:  Amy W Pollak; Patrick T Norton; Christopher M Kramer
Journal:  Circ Cardiovasc Imaging       Date:  2012-11       Impact factor: 7.792

3.  [Prognostic value of cardiovascular MRI in diabetics].

Authors:  C L Schlett; R C Bertheau; H-U Kauczor; S Weckbach
Journal:  Radiologe       Date:  2015-04       Impact factor: 0.635

4.  Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three different contrast agents at two different doses (0.05 and 0.1 mmol/kg) in pigs at 1.5 Tesla.

Authors:  M Voth; Henrik J Michaely; C Schwenke; B Vos; H Pietsch
Journal:  Eur Radiol       Date:  2010-09-01       Impact factor: 5.315

5.  High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort.

Authors:  Anjali B Nayak; Aarti Luhar; Mark Hanudel; Barbara Gales; Theodore R Hall; J Paul Finn; Isidro B Salusky; Joshua Zaritsky
Journal:  Pediatr Nephrol       Date:  2014-09-12       Impact factor: 3.714

6.  "Number needed to read"--how to facilitate clinical trials in MR-angiography.

Authors:  M Voth; U I Attenberger; A Luckscheiter; S Haneder; T Henzler; S O Schoenberg; C Schwenke; H J Michaely
Journal:  Eur Radiol       Date:  2010-10-23       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.